Careers Media center Contacts

EPIRUBICIN




Active substance: еpirubicin hydrochloride

ATC: L01D B03

How supplied: Solution for injection

Dosage form
Solution for injection 5 ml №1 or 25 ml №1.

Active ingredient
Epirubicin hydrochloride.

Indications
Breast cancer; common ovarian cancer; gastric cancer, liver cancer, pancreatic cancer, rectal cancer; lung cancer; soft tissue sarcoma; head and neck cancer; cancerous lymphoma; leukemias. When intravesical use: perehodnokletochny papillary cancer of the bladder; carcinoma in situ; prevention of recurrence of superficial bladder cancer after transurethral resection.

 

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form